Departamento académico
(FM) Inmunología
Publicaciones (20) Publicaciones en las que ha participado algún/a investigador/a
2017
-
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Journal of Translational Medicine, Vol. 15, Núm. 1
-
A simple flow-cytometry method to evaluate peripheral blood contamination of bone marrow aspirates
Journal of Immunological Methods, Vol. 442, pp. 54-58
-
Anti-CD137 and PD-1/PD-L1 antibodies en route toward clinical synergy
Clinical Cancer Research, Vol. 23, Núm. 18, pp. 5326-5328
-
Antibody-dependent cell cytotoxicity: Immunotherapy strategies enhancing effector NK cells
Immunology and Cell Biology, Vol. 95, Núm. 4, pp. 347-355
-
Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies
Brachytherapy, Vol. 16, Núm. 6, pp. 1246-1251
-
Cellular immunotherapies for cancer
OncoImmunology, Vol. 6, Núm. 5
-
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
Annals of Oncology, Vol. 28, Núm. 8, pp. 1988-1995
-
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study
European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43
-
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
PLoS ONE, Vol. 12, Núm. 9
-
Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer
Cancer Discovery, Vol. 7, Núm. 12, pp. 1420-1435
-
Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium
International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 2, pp. 389-400
-
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Cancer Treatment Reviews, Vol. 60, pp. 24-31
-
Intratumoral delivery of immunotherapy - Act locally, think globally
Journal of Immunology, Vol. 198, Núm. 1, pp. 31-39
-
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
The Lancet, Vol. 389, Núm. 10088, pp. 2492-2502
-
Predictors of responses to immune checkpoint blockade in advanced melanoma
Nature Communications, Vol. 8, Núm. 1
-
Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody
Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
-
T Cell Migration from Inflamed Skin to Draining Lymph Nodes Requires Intralymphatic Crawling Supported by ICAM-1/LFA-1 Interactions
Cell Reports, Vol. 18, Núm. 4, pp. 857-865
-
Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment
Cancer Cell, Vol. 31, Núm. 3, pp. 396-410
-
Targeting NK-cell checkpoints for cancer immunotherapy
Current Opinion in Immunology, Vol. 45, pp. 73-81